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Introduction: This study investigated the effectiveness of extracorporeal shockwave therapy (ESWT) in osteoporotic
(OP) osteoarthritis (OA) of rat knee.
Methods: Fifty-six rats were divided into seven groups including sham, OA, OP, OA + OP, OA + ESWT, OP + ESWT,
and OA +OP + ESWT groups. The evaluations included gross pathology, bone mineral density (BMD), micro-computed
tomography (micro-CT) scan, bone-strength test, histopathologic examination, and immunohistochemical analysis.
Results: On gross pathology, group OA +OP showed larger areas of osteoarthritic changes than did groups OA and OP,
as compared with the sham group. BMD and bone strength significantly decreased in groups OA, OP, and OA +OP
relative to the sham group, and ESWT significantly improved BMD and bone-strength changes. On micro-CT scan, the
subchondral plate thickness significantly decreased, and the bone porosity increased in groups OA, OP, and OA +OP,
and ESWT significantly improved the changes in subchondral-plate thickness and bone porosity. In histopathologic
examination, Mankin score and safranin O score significantly increased in groups OA and group OA +OP, but not in
group OP relative to the sham group, and ESWT significantly improved the changes. In immunohistochemical analysis,
Dickkopf-1 (DKK-1) significantly increased, but vessel endothelial growth factor (VEGF), proliferating cell nuclear antigen
(PCNA), and bone morphogenetic protein 2 (BMP-2) decreased in groups OA, OP, and OA +OP relative to the sham
group, and ESWT significantly reversed the changes.
Conclusions: Osteoporosis increased the severity of cartilage damage in osteoarthritis of the knee. ESWT showed
effectiveness in the reduction of osteoporotic osteoarthritis of the knee in rats.Introduction
Osteoarthritis (OA) and osteoporosis (OP) are common
musculoskeletal disorders. The prevalence of OA and
OP escalates with age, especially in women after meno-
pause [1]. OP often manifests in the early stage of OA of
the knee, accelerates OA changes with physical inability
and functional disability, and directly increases the
health-care cost [2-5]. The etiology of OA is multifactorial,
including aging, excessive loading to the joint, trauma, in-
fection, overweight, and metabolic disease, and so on [1,6].
OA of the knee is perceived primarily as a cartilage disease* Correspondence: w281211@adm.cgmh.org.tw
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unless otherwise stated.accompanied by changes in the subchondral and periarticu-
lar bone, such as sclerosis, bone cyst, and osteophyte
formation [1,7,8]. Likewise, the etiology of OP is also multi-
factorial, including estrogen deficiency, disuse atrophy, and
infection, and has a direct link to hormone imbalance
[9-12]. OP can result in a decrease in bone mineral density,
deterioration of bone quality, and microarchitectural frac-
ture of the subchondral bone [13-18]. OP may increase the
severity of cartilage damage in OA knee, and the increases
in cartilage damage correlate with bone loss and microarch-
itectural changes [13,14,17,19]. These findings suggest an
intimate relation between OP and OA.
Recent studies demonstrated that application of ESWT
to subchondral bone of the proximal tibia shows a chon-
droprotective effect in the initiation of OA of the knee
and induces regression of established OA of the knee in
rats [20-22]. ESWT was noted to have multifunctionaltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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apoptosis of chondrocytes [23]. Our study showed that
increased DKK-1 expression correlated with the occur-
rence of knee OA. Interruption of DKK-1 expression
may ameliorate OA-induced chondrocyte apoptosis, car-
tilage loss, and subchondral bone damage [24], as well as
decreased synovitis and hypervascularity in animals with
OA knee [25].
In clinical application, ESWT has been effective in
the treatment of nonunion of long-bone fractures, and
tendinopathy of the shoulder, elbow, knee, and heel. In
animal experiments, ESWT was shown to promote bone
healing and tissue repair with ingrowth of neovasculari-
zation and upregulation of angiogenic and osteogenic
growth factors, such as VEGF, endothelial nitric oxide
synthase (eNOS), PCNA, BMP-2, and osteocalcin [26].
DKK-1, PCNA, VEGF, and BMP-2 play an important
role in wound healing, cartilage repair, and bone synthe-
sis [20,25,27]. For angiogenesis, significant elevations of
VEGF, vWF, and FGF basic and a decrease of TGF-β1
were observed. For osteogenesis, BMP-2, osteocalcin, al-
kaline phosphatase, and IGF were significantly elevated,
whereas DKK-1 was decreased. DKK-1 is involved in
embryonic development through the inhibition of the
Wnt signaling pathway. VEGF is an indication of in-
creased vascular permeability and microvascular activity,
including the growth of new vessels. BMP-2 plays an
important role in the development of bone and cartilage.
These studies demonstrate that ESWT has a potential
function of inducing osteoblast differentiation in a var-
iety of cell types. Other studies showed that DKK-1 and
Wnt/β-catenin pathways play an important role in the
remodeling of subchondral bone, with bone formation
and resorption that may link to the development of OP
and OA [28,29].
No report has shown an effective method in the pre-
vention or reduction of osteoporotic osteoarthritis of the
knee. The purpose of this study was to investigate the ef-
fectiveness of ESWT in osteoporotic osteoarthritis of the
knee in rats. We hypothesized that ESWT may be effect-




Fifty-six 8-weeks-old female Sprague–Dawley (SD) rats
(BioLASCO, Taipei, Taiwan) were used in the experi-
ment. The experimental protocol of the animal study
was approved by the Animal Care Committee of
Kaohsiung Chang Gung Memorial Hospital. The ani-
mals were kept at the Laboratory Animal Center for
1 week before experiment. The rats were housed at
23°C ± 1°C with a 12-hour light-and-dark cycle and
given food and water.SD rats were randomly divided into seven groups with
eight rats in each group. Group 1 was designated the
sham group and received sham laparotomy without
ovariectomy and sham arthrotomy of the left knee
without anterior cruciate ligament transaction (ACLT)
or medial meniscectomy (MM). Group 2 was designated
the OA group and received ACLT and MM of the left
knees [8]. Group 3 was designated the OP group and
received bilateral ovariectomies [30]. Group 4 was desig-
nated the OA +OP group and received ACLT and MM
of the left knee and bilateral ovariectomies. Group 5 was
designated the OA + ESWT and received ACLT +MM of
the left knee and ESWT. Group 6 was designated the
OP + ESWT and received bilateral ovariectomies plus
ESWT. Group 7 was designated the OA +OP + ESWT
and received ACLT and MM of the left knee, bilateral
ovariectomies, and ESWT.
Postoperatively, the animals were cared for by a
veterinarian. The surgical site and the activities of the
animals were observed daily. After BMD measurement,
all animals were killed at 12 weeks after surgery. Left-
knee specimens were harvested for examination of
gross pathologic lesions, micro-CT scan, bone-strength
test, histopathologic examination, and immunohisto-
chemical analysis.
Anterior cruciate ligament transection and medial
meniscectomy
The left knee was prepared in a surgically sterile fashion.
Through miniarthrotomy, the ACL was transected with
a scalpel, and MM was performed by excising the entire
medial meniscus. The knee joint was irrigated, and the
incision was closed. Prophylactic antibiotics with ampi-
cillin, 50 mg/kg body weight, were given for 5 days after
surgery. Postoperatively, the animals were cared for by a
veterinarian. The surgical site and the activities of the
animals were observed daily.
Laparotomy and bilateral ovariectomies
The rats were anesthetized with an intramuscular
injection of phenobarbital (50 mg/kg body weight). The
abdomen was scrubbed and prepared in surgically sterile
fashion. A midline incision was made, and laparotomy
was performed. Bilateral ovariectomies were performed
by excision of both ovaries. The wound was irrigated
and closed in routine fashion.
Application of shockwave
ESWT was performed in half of animals (eight rats with
eight knees in each group) at 1 week after surgery when
the wounds healed. The animals were sedated with a 1:1
volume mixture of Rompun (containing xylazine; 5 mg/kg)
with Zoletil (containing zolazepam and tiletamine;
20 mg/kg) while receiving ESWT. The source of the
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GA, USA). Application of 800 impulses of shockwave
at energy-flux density of 0.22 mJ/mm2 was given to the
proximal medial tibial condyle at 0.5 cm below the
joint line and 0.5 cm from the medial skin edge in a
single session [27,31,32].Bone mineral density
The BMD values within the region of interest (ROI) in
medial proximal tibia and distal femur condyle was
measured by using dual-energy X-ray absorptiometry
(DEXA) (Hologic QDR 4500 W, Hologic, Bedford,
MA, USA) before the animals were killed. BMD was
used to assess the changes in bone density around the
knee in different conditions.The score of pathologic lesions
The knee joint was examined under a magnification scope.
The gross pathologic lesions with arthritic changes on
femoral condoyle and tibial plateau were identified and
quantified separately by the semiquantitative scale [19], The
severity of joint-surface damage was scored and categorized
as follows: (a) normal, (b) discoloration, mild surface irregu-
larities or pitting, (c) partial-thickness erosion or fibrillation,
and (d) full-thickness erosion and/or osteophytes. The over-
all scores were obtained by summing the cartilage scores of
the lesions in femoral condoyle and tibial plateau cartilages
in eight knees of each group [19].Micro-CT scan
The proximal part of the tibia and the distal part of the
femur were scanned by a micro-CT scanner (Skyscan
1076; Skyscan, Luxembourg, Belgium) with isotropic
voxel size of 36 × 36 × 36 μm3, as previously described
[33]. In brief, the X-ray voltage was set at 100 kV, and
the current, at 100 μA. X-ray projections were obtained
at 0.75-degrees angular step with a scanning angular
range of 180 degrees. Reconstructions of the image slices
were performed with NRecon software (Skyscan), and
the process generated a series of planar transverse gray-
value images. Volume of interest (VOI) of bone morph-
ometry was selected with a semiautomatic contouring
method by Skyscan CT-Analyser Software (Skyscan).
Three-dimensional cross-sectional images of the femoral
and tibial subchondral bone regions were generated by
CTVol v2.0 software. The subchondral porosity was de-
fined as the ratio of the volume of the pores to the total
volume of the subchondral region. The subchondral
plate thicknesses of the femur and tibia were measured
by individual point-to-point distance from the top of the
cartilage to the subchondral bone plate by averaging at
least six measurements per sample.Bone-strength test
The distal femur and proximal tibia bones were harvested
for bone-strength tests, including peak load and breaking
moment. A 3-cm bone from the medial proximal tibia and
distal femur was obtained. The bone specimens were sub-
jected to bone-strength tests on a Material Testing System
(MTS, Synergie 200; Canton, MA, USA) machine. The
peak compression strength and the breaking moment of
inertia were measured by using the slow-load compression
technique until fracture occurred.
Histopathologic examination
The bone and cartilage of the knee were subjected to
histopathologic examination. The harvested specimens
are fixed in 4% PBS-buffered formaldehyde and decalci-
fied in 10% PBS-buffered EDTA at room temperature
for about 2 months. Decalcified specimens were sub-
jected to paraffin-wax embedding and dissection into
5-μm-thick sections. The specimens were stained with
hematoxylin-eosin (H&E) stain and safranin O staining.
The degenerative changes of the cartilage were graded
histologically by using the Mankin scoring system for
the assessments of cartilage structure, cartilage cells,
and tidemark integrity, with a score from 0 to 15 [7].
In addition, a safranin O score was obtained according
to the Osteoarthritis Research Society International
(OARSI) cartilage OA grading system [34]. The scores
were obtained on a 0–to-24 scale by multiplying the
index of grades with stages.
Immunohistochemical analysis
The harvested knee specimens were fixed in 4% PBS-
buffered formaldehyde for 48 hours and decalcified in
10% PBS-buffered EDTA solution. Decalcified tissues
were embedded in paraffin wax. The specimens were cut
longitudinally into 5-μm-thick sections and transferred
to polylysine-coated slides (Thermo Fisher Scientific,
Waltham, MA, USA). The immunohistochemical stains
were done by following the protocol provided in the
immunostaining kit (Abcam, Cambridge, MA, USA). In
brief, tissue sections were deparaffinized in xylene,
hydrated in graded ethanol, and treated with peroxide-
block and protein-block reagents. Sections of the speci-
mens were immunostained with specific antibodies for
DKK-1 (Cell Signaling Technology, Danvers, MA, USA),
PCNA (Santa Cruz Biotechnology, Santa Cruz, CA,
USA), VEGF (Santa Cruz Biotech), and BMP-2 (Abcam)
for overnight to identify the angiogenesis and osteogen-
esis biomarkers according to the product immunohisto-
chemical staining protocols. The immunoreactivity in
specimens was demonstrated by using a goat anti-rabbit
horseradish peroxidase (HRP)-conjugated and 3′,3′-dia-
minobenzendine (DAB), which were provided in the kit.
The immunoactivities were quantified from five areas in
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Axioskop 2 plus microscope (Carl Zeiss, Gottingen,
Germany). All images of each specimen were captured
by using a cool CCD camera (Media Cybernetics, Silver
Spring, MD, USA). Images were analyzed by using
an Image-Pro Plus image-analysis software (Media
Cybernetics). The percentages of immunolabeled posi-
tive cells over the total cells were calculated from ar-
ticular cartilage and subchondral bone of distal femur
and proximal tibia.
Statistical analysis
SPSS ver. 17.0 (SPSS Inc., Chicago, IL, USA) was used in
statistical analysis. Data were expressed as mean ± SD.
One-way ANOVA and Tukey tests were used to com-
pare sham versus OA, OP, and OA +OP with ESWT
and without ESWT (designated as *P < 0.05 and **P <
0.001). Paired sample t tests were used to compare
ESWT groups and without-ESWT groups (designated
as #P < 0.05 and ##P < 0.001) and independent-sample t
tests were used to compare OA versus OA+OP and OA+Figure 1 Gross pathologic lesions in a rat model of OA knee in sham,
scores of the pathologic lesions were measured and calculated, and the re
groups as compared with sham (indicated as **P < 0.01). ESWT significantly
without ESWT (indicated as #P < 0.05). The OA + OP group has significantly
respectively (B) (indicated as ※P < 0.05 and ※※P < 0.001); n = 8.ESWT versus OA+OP + ESWT (designated as ※P < 0.05
and ※※P < 0.001). The P values of less than 0.05 were
considered significant.
Results
ESWT reduces arthritic area of injury joint
Significant difference in the sizes of gross arthritic le-
sions of the knee was noted between ESWT and non-
ESWT. The gross pathologic lesions with and without
ESWT are shown in Figure 1A. With no ESWT, the
sham group showed smooth surfaces with no surface
irregularity or pits. The OA group demonstrated broad
areas of articular surface destruction with fibrous tissue
thickening around the tibia. The OP group showed
intact surfaces with decreased surface brightness and in-
flammation. The OA +OP group showed severe articular
surface erosion, ulcerations, pitting, and osteophytes with
proliferation of fibrous tissue. With ESWT, the OA group
showed thickening of the articular surface with yellowish
discoloration but no osteophytes. The OP group showed
intact surfaces with no ulceration or discoloration. TheOA, OP, and OA +OP groups with and without ESWT (A). The
sults showed significantly higher lesion scores in OA and OA + OP
decreased the total score of pathologic lesions as compared with
higher lesion score than the OA group with and without ESWT,
Figure 2 The BMD values were measured from the region of
interest in the knee. BMD values significantly decreased in OA, OP,
and OA + OP groups as compared with sham without ESWT. ESWT
significantly increased the BMD values in OA, OP, and OA + OP
groups relative to sham (indicated as *P < 0.05 and **P < 0.001). The
BMD values in animals treated with ESWT showed significant
improvement as compared with animals without ESWT (indicated as
#P < 0.05). The OA group showed significantly higher BMD values
than the OA + OP group, with and without ESWT, respectively
(indicated as ※P < 0.05 and ※※P < 0.001); n = 8.
Figure 3 Bone-strength tests included peak load and breaking mome
and tibia (B) showed significantly higher values in the OA group as compa
(indicated as *P < 0.05, ※P < 0.05, and ※※P < 0.001). The animals with ESW
ESWT (indicated as #P < 0.05). The breaking moment of inertia in the femur
group than in the OP and OA + OP groups, with and without ESWT, respec
a significantly higher breaking moment than did those without ESWT (indi
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cluding articular-surface erosions, ulcerations, pitting, and
osteophyte formation. The statistical comparisons be-
tween ESWT and no ESWT are shown in Figure 1B; the
OA and OA+OP groups showed significantly larger areas
than the sham group. The OA and OA +OP group with
no ESWT showed significantly larger lesions than OA and
OA+OP with ESWT. The OA+OP group with ESWT
showed significantly larger lesions than did those with no
ESWT. It appears that ESWT is effective to ameliorate the
severity of osteoporotic osteoarthritis in rat knee.ESWT enhances BMD and bone strength
BMD values were measured with and without ESWT
(Figure 2). BMD significantly decreased in groups OA,
OP, and OA + OP, as compared with sham. ESWT
significantly increased BMD in OA, OP, and OA + OP,
as compared with sham. BMD was significantly higher
with ESWT than without ESWT in OA, OP, and OA +
OP groups.
The bone-strength tests are shown in Figure 3. The peak
load (Figure 3A,B) and the breaking moment of the femur
and tibia (Figure 3C,D) significantly decreased in groups
OA, OP, and OA+OP relative to sham group, with thent of inertia with and without ESWT. The peak load in femur (A)
red with OP and OA + OP, with and without ESWT, respectively
T showed significantly greater values than did the animals without
(C) and tibia (D) demonstrated significantly higher values in the OA
tively (indicated as *P < 0.05, ※P < 0.05). ESWT-treated animals showed
cated as #P < 0.05); n = 8.
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proved the peak load and breaking moment in groups OA,
OP, and OA+OP as compared with the sham group. The
results showed that ESWT significantly improved the BMD
value and bone strength in osteoporotic osteoarthritis of
the knee in rats.
ESWT improves subchondral plate thickness and bone
porosity
The results of micro-CT scan are summarized in Figure 4.
The subchondral plate thickness significantly decreased,
and bone porosity increased in distal femur and proximal
tibia in groups OA, OP, and OA+OP, with the most de-
crease noticed in group OA+OP as compared with sham.Figure 4 Micro-CT images showed morphology and distribution of su
without ESWT (A). The subchondral plate thicknesses of femur (B) and tib
compared with sham (indicated as *P < 0.05 and **P < 0.001). ESWT-treated
ESWT (indicated as #P < 0.05). The OA group showed significantly thicker su
respectively (indicated as ※P < 0.05 and ※※P < 0.001). The bone porosities
and OA + OP groups as compared with sham with or without ESWT (indica
groups OA, OP, and OA + OP, as compared with sham (indicated as #P < 0.
did the OP and OA + OP groups with ESWT and without ESWT, respectively
1 mm; n = 8.ESWT significantly improved the subchondral plate thick-
ness and bone porosity in groups OA, OP, and OA+OP,
especially in group OA+OP. ESWT seems more effective
in the improvement of subchondral plate thickness and
bone porosity in group OA+OP than in group OA.
ESWT reduces cartilage damage in knee osteoarthritis
The microscopic features of histopathologic examination
of groups OA, OP, and OA +OP are shown in Figure 5A.
The graphic illustrations with and without ESWT are
shown in Figure 5B for Mankin score and Figure 5C for
safranin O stain. Significant cartilage damage associated
with elevations of Mankin score and safranin O stain
were observed in groups OA and OA +OP, but not inbchondral bone of distal femur and proximal tibia with and
ia (C) were significantly reduced in OA, OP, and OA + OP groups as
groups showed significantly higher values than did those without
bchondral plates than did the OA + OP group, with and with ESWT,
of femur (D) and tibia (E) showed increased bone porosity in OA, OP,
ted as *P < 0.05). ESWT significantly reduced the bone porosity in
05). The OA group showed significantly lower bone porosity than
(indicated as ※P < 0.05 and ※※P < 0.001). The scale bar represents
Figure 5 Histopathologic examination showed the cartilage damages in osteoarthritis of the knee, as shown in arrows with and
without ESWT (A). Mankin score (B) and safranin O (C) score significantly increased in OA and OA + OP groups, as compared with sham with
and without ESWT (indicated as *P < 0.05). ESWT significantly reduced Mankin and safranin O scores (indicated as #P < 0.05). Mankin and safranin
O scores were significantly higher in the OA + OP group than in the OA group. ESWT, significantly decreased Mankin and safranin O scores in OA
and OA + OP group (indicated as ※P < 0.05). The scale bar represents 200 μm; n = 8. Arrow indicates cartilage injury. Arrowhead indicates
spongy bone.
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improved the cartilage changes with decreases in
Mankin score and safranin O stain in groups OA and
OA + OP. (Figures 5B,C). These findings suggest that
the ESWT shows chondroprotective effect in groups
OA, OP, and OA +OP.
ESWT causes favorable molecular changes in knee
osteoarthritis
Immunohistochemical analysis of DKK-1, PCNA, VEGF,
and BMP-2 in subchondral bone and articular cartilage
in OA, OP, and OA +OP with and without ESWT is
shown in Figure 6A-D. The representative images of
microscopic features are shown in Figure 6a-d. Signifi-
cant increases in DKK-1 expression (Figure 6A) and
decreases in PCNA (Figure 6B), VEGF (Figure 6C), and
BMP-2 (Figure 6D) expressions were noted in groups
OP and OA +OP with and without ESWT, as compared
with the sham group. ESWT significantly improved the
changes in DKK-1, PCNA, VEGF, and BMP-2, with the
most changes noticed in group OA +OP. These results
demonstrated that ESWT modulates the key factors for
joint repair in groups OA, OP, and OA +OP.
Discussion
The most significant findings of the current study revealed
that OP increases the severity of cartilage damage in OA ofthe knee in rats. Osteoporotic OA resulted in the most
severe form of arthritic changes of the knee, as shown
on gross pathology, BMD, bone strength, micro-CT scan,
histopathologic examination, and immunohistochemical
analysis. The relation between osteoporosis and osteoarth-
ritis remains debated. Some studies reported that OP in-
creased the severity of cartilage damage in OA [19]. Others
reported an inverse relation between bone density and bone
turnover in patients with OA and OP [13-18].
OP is often present in an early stage of osteoarthritis
with bone loss and microarchitectural damage or tra-
becular fracture in subchondral bone [15,18]. As the
subchondral bone fracture heals, it often results in less
compliant and harder bone tissue that in turn causes de-
generative changes of the articular cartilage [35-37].
Many studies, including the current study, reported a
close relation between OP and OA [13-16].
In this study, ESWT showed beneficial effects in osteo-
porotic OA in rat knee. Prior studies reported that ESWT
has chondroprotective effects in ACLT-induced OA knee
in rats [20-22]. Zhao and his colleagues [22] reported that
ESWT reduces the progression of knee OA in rabbits by
reducing the nitric oxide level and chondrocyte apoptosis.
The results of the current study are in agreement with
others that shockwave therapy showed chondroprotec-
tive effects in the development of OA changes of the
knee in animal experiment [20,27,31,32].
Figure 6 Immunohistochemical analysis for molecular changes in osteoarthritis of the knee with and without ESWT in representative
images of microscopic features, and the results, in graphs. DKK-1 expressions (A and a) were significantly higher in OA, and OA + OP groups,
but not in the OP group as compared with the sham group (indicated as *P < 0.05 and **P < 0.001). ESWT significantly decreased the DKK-1
expressions, as compared with those without ESWT (indicated as #P < 0.05 and ##P < 0.001). DKK-1 expression was significantly higher in the OA +
OP group than in the OA group and decreased after ESWT (indicated as ※P < 0.05 and ※※P < 0.001). The expressions of PCNA (B and b), VEGF
(C and c) and BMP-2 (D and d) were significantly decreased in the OA, OP, and OA + OP groups, and the data increased after ESWT (indicated as
*P < 0.05 and **P < 0.001). ESWT significantly increased PCNA, VEGF, and BMP-2 expressions, as compared with those without ESWT (indicated as
#P < 0.05 and ##P < 0.001). The PCNA, VEGF, and BMP-2 expressions in the OA group significantly decreased as compared with the OA + OP group
after ESWT (indicated as ※P < 0.05 and ※※P < 0.001). The scale bar represents 50 μm; n = 8. The arrows indicate the level of molecular expression
in subchondral bone.
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subchondral bone of the medial proximal tibia results
in a chondroprotective effect associated with improved
subchondral bone remodeling [28,30]. The relationbetween subchondral bone changes and the initiation
and progression of OA changes in the knee remains
debated. Emerging evidence showed that subchondral
bone changes may play a role in OA changes of the
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to the subchondral bone may reduce or retard the initi-
ation or progression of knee OA [9,10,35-37].
The results of the current study showed that early
intervention with ESWT resulted in chondroprotective
effect in the initiation of OA changes of the rat knee.
The functional integrity of the articular cartilage relies
on the mechanical property of the subchondral bone
[35,37]. Radon and his colleagues [35] proposed the
potential role of subchondral bone in the initiation and
progression of OA knees. Remodeling of subchondral
bone plate that is exposed to excessive no physiological
mechanical load results in stiffer bone of inhomogen-
eous density with poor shock absorption. The denser
and less compliant bone can generate shear stress that
alters the physiological deformation and cartilage damage.
It was suggested that increased subchondral bone stiffness
can reduce the ability of the knee joint to dissipate the load
and distribute the forces within the joint, and subsequently
increases the force loads on the overlying articular cartilage,
which in turn accelerates the cartilage damage over time
[13-17].
Emerging evidence indicates that bone turnover in-
creases in patients with early OA changes of the knee
[9,10]. As the OA changes progressed, increased bone
resorption and reduced subchondral bone volume occur,
and finally, the process is followed by increased bone
formation and increased subchondral bone volume
(sclerosis) and formation of periarticular osteophytes
[18,37]. It appears that a close link exists between OP
and OA. The OA of the knee is perceived primarily as a
cartilage disease; however, many recent studies, in-
cluding the current study, raised the possibility that
subchondral bone changes may precede the articular
cartilage changes in the development of OA of the
knee [15,16,37].
Some limitations exist in this study. The results of this
study are based on studies in a limited number of small
rats. The results may vary in larger animals and human
subjects. The radiographic appearance of the knee was
not shown because radiographs are insensitive and
inaccurate in the quantitative assessment of OA of the
knee in small animals. The ESWT dose was based on a
pilot study in small animals, and validation of shockwave
dosage may be necessary.
Conclusion
OP increases the severity of cartilage damage in OA of
the knee in rats. ESWT is effective in the amelioration
of osteoporotic OA of the knee in rats.
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